Search Results

You are looking at 111 - 120 of 1,455 items for :

  • Refine by Access: Content accessible to Me x
Clear All
Full access

EPR19-075: Geographic Region and Race/Ethnicity Are Associated With Treatment and Survival for Gastric Cancer

Mark Ulanja, Mohit Rishi, Bryce Beutler, and Santhosh Ambika

adenocarcinoma (AJCC I–III) diagnosed 2004 to 2015. Exposures of interest were geographic region of diagnosis: Western (West), Midwestern (MW), Southern (SO) or North Eastern (NE), and race. The endpoints were: (1) recommendation of no surgery by the provider, (2

Full access

CLO19-054: Initial Experience of a Newly Set-up Robotic Assisted Radical Prostatectomy Program From a Developing Country—Delineating the Learning Curve

Shantanu Tyagi, Arandam Roy, Ravimohan Mavuduru, Girdhar Bora, Tushar Aditya Narain, and Arup Kumar Mandal

) among postoperative patients from a tertiary care center of a developing country. Materials & Method: Prospective cohort/next 50 group, surgery between July 2017 to September 2018: Preoperative variables included demographic profile, MRI findings, PSA

Full access

Minimally Invasive Techniques for Treating Gynecologic Malignancies

Amanda N. Fader

and Obstetrics, The Johns Hopkins School of Medicine. In fact, less may be more when it comes to minimally invasive surgery (MIS) for the primary treatment of certain gynecologic cancers, she added. Dr. Fader is an editorial board member for

Full access

Where Does Photodynamic Therapy Fit in the Esophageal Cancer Treatment Jigsaw Puzzle?

Keyvan Moghissi

Although surgery still holds “the highest place” in treatment of operable esophageal cancer, photodynamic therapy (PDT) represents an effective, minimally invasive treatment option in selected patients, declared Keyvan Moghissi, BSc, MD, MS, FRCS

Full access

Multidisciplinary Management of Early-Stage Rectal Cancer

John G. Phillips, Theodore S. Hong, and David P. Ryan

) 79-47-51 randomized 204 patients with locally advanced rectal cancer treated with surgery to either postoperative radiation to 50.4 Gy or the same radiation regimen with concurrent bolus 5-FU with semustine both preceded and followed by adjuvant 5-FU

Full access

Counterpoint: Adjuvant Therapy in Stage II Colon Cancer: Pain Not Justified by the Gain

Katherine Van Loon and Alan P. Venook

who undergo a complete resection of node-positive stage III tumors, adjuvant FOLFOX achieves an estimated one-third reduction in the risk of recurrence compared with surgery alone. 9 The existing evidence for the role of adjuvant therapy is largely

Full access

New NCCN Guidelines for Vulvar Cancer

Benjamin E. Greer and Wui-Jin Koh

excision, separate groin incision, lymphatic mapping, radiation, chemotherapy, and exenteration. Surgery The goal of primary surgery is to obtain an adequate negative margin of 1 to 2 cm, Dr. Greer told the audience. Early-stage tumors (T1, smaller T2

Full access

Principles of Surgical Management of Peritoneal Mesothelioma

Jessica A. Steadman and Travis E. Grotz

, 2 Radical resection with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) remains the primary curative therapy for malignant peritoneal mesothelioma (MPeM), and the strongest predictor of long-term survival is

Full access

NCCN Guidelines Update: Evolving Radiation Therapy Recommendations for Breast Cancer

Kilian E. Salerno

Cancer Panel. Adjuvant RT After Breast-Conserving Surgery In short, the NCCN recommendations for RT of invasive breast cancer after breast-conserving surgery include RT to the whole breast, with or without a boost; APBI in select patients; and

Full access

Early Postoperative Mortality Among Patients Aged 75 Years or Older With Stage II/III Rectal Cancer

Helmneh M. Sineshaw, K. Robin Yabroff, V. Liana Tsikitis, Ahmedin Jemal, and Timur Mitin

with locally advanced rectal cancer (LARC) in the United States using data from the National Cancer Database (NCDB). 8 Patients who received concurrent chemoradiation therapy without surgery had lower survival rates. 8 Others, however, used